Search bioRxiv⌕ Search

Biology subjects

Rapakoulia, T.

Publications and source records attributed to Rapakoulia, T..

3 recordsLinked to original sources

CENTRE: A gradient boosting algorithm for Cell-type-specific ENhancer-Target pREdiction

MotivationIdentifying target promoters of active enhancers is a crucial step for realizing gene regulation and deciphering phenotypes and diseases. Up to now, several computational methods were developed to predict enhancer gene interactions but they require either many epigenomic and transcriptomic experimental assays to generate cell-type-specific predictions or a single experiment applied to a large cohort of cell types to extract correlations between activities of regulatory elements. Thus, inferring cell-type-specific enhancer gene interactions in unstudied or poorly annotated cell types becomes a laborious and costly task. ResultsHere, we aim to infer cell-type-specific enhancer target interactions, using minimal experimental input. We introduce CENTRE, a machine learning framework that predicts enhancer target interactions in a cell-type-specific manner, using only gene expression and ChIP-seq data for three histone modifications for the cell type of interest. CENTRE exploits the wealth of available datasets and extracts cell-type agnostic statistics to complement the cell-type specific information. CENTRE is thoroughly tested across many datasets and cell types and achieves equivalent or superior performance than existing algorithms that require massive experimental data. AvailabilityCENTREs open source code is available at GitHub via https://github.com/slrvv/CENTRE

bioinformatics↗

Deep learning identifies and quantifies recombination hotspot determinants

Recombination is one of the essential genetic processes for sexually reproducing organisms, which can happen more frequently in some regions, called recombination hotspots. Although several factors, such as PRDM9 binding motifs, are known to be related to the hotspots, their contributions to the recombination hotspots have not been quantified, and other determinants are yet to be elucidated. Here, we develop a computational method, RHSNet, based on deep learning and signal processing, to identify and quantify the hotspot determinants in a purely data-driven manner, utilizing datasets from various studies, populations, sexes, and species. In addition to being able to identify hotspot regions and the well-known determinants accurately, RHSNet is sensitive to the difference between different PRDM9 alleles and different sexes, and can generalize to PRDM9-lacking species. The cross-sex, cross-population, and cross-species studies suggest that the proposed method has the potential to identify and quantify the evolutionary determinant motifs. TeaserRHSNet can accurately identify and quantify recombination hotspot determinants across different studies, sexes, populations, and species.

bioinformatics↗

Automatic identification of small molecules that promote cell conversion and reprogramming

Controlling cell fate has great potential for regenerative medicine, drug discovery, and basic research. Although numerous transcription factors have been discovered that are able to promote cell reprogramming and trans-differentiation, methods based on their up-regulation tend to show low efficiency. The identification of small molecules that can facilitate conversion between cell types can ameliorate this problem working through safe, rapid, and reversible mechanisms. Here we present DECCODE, an unbiased computational method for the identification of such molecules solely based on transcriptional data. DECCODE matches the largest available collection of drug-induced profiles (the LINCS database) for drug treatments against the largest publicly available dataset of primary cell transcriptional profiles (FANTOM5), to identify drugs that either alone or in combination enhance cell reprogramming and cell conversion. Extensive in silico and in vitro validation of DECCODE in the context of human induced pluripotent stem cells (hIPSCs) generation shows that the method is able to prioritize drugs enhancing cell reprogramming. We also generated predictions for cell conversion with single drugs and drug combinations for 145 different cell types and made them available for further studies.

bioinformatics↗